Evidence map›Paper›PMID 22731751›Full record

ArticleArthritis research & therapy2012

Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis.

María Teruel, Carmen P Simeon, Jasper Broen, Madelon C Vonk, Patricia Carreira, Maria Teresa Camps, Rosa García-Portales, Esmeralda Delgado-Frías, Maria Gallego, Gerard Espinosa and 16 more

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 17 institutions in 5 countries.

María TeruelInstituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, Avda, del Conocimiento s/n, 18010, Granada, SpainArmilla (Granada), Spain. mteruel@ipb.csic.es
Carmen P Simeon
Jasper Broen
Madelon C Vonk
Patricia Carreira
Maria Teresa Camps
Rosa García-Portales
Esmeralda Delgado-Frías
Maria Gallego
Gerard Espinosa
Spanish Scleroderma Group
Lorenzo Beretta
Paolo Airó
Claudio Lunardi
Gabriela Riemekasten
Torsten Witte
Thomas Krieg
Alexander Kreuter
Jörg H W Distler
Nicolas Hunzelmann
Bobby P Koeleman
Alexandre E Voskuyl
Annemie J Schuerwegh
Miguel Angel González-Gay
Timothy R D J Radstake
Javier Martin
University of Cologne · DEFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITInstituto de Parasitología y Biomedicina "López - Neyra" · ESLeiden University Medical Center · NLRadboud University Nijmegen · NLUniversity of Verona · ITUtrecht University · NLFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHebron University · PSHospital Clínic de Barcelona · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital Universitario Central de Asturias · ESHospital Universitario de Canarias · ESHospital Universitario Rey Juan Carlos · ESMarqués de Valdecilla University Hospital · ESMedizinische Hochschule Hannover · DEResearch Institute Hospital 12 de Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of the present study was to investigate the possible role of CD40 and CD40 ligand (CD40LG) genes in the susceptibility and phenotype expression of systemic sclerosis (SSc).

methodsIn total, 2,670 SSc patients and 3,245 healthy individuals from four European populations (Spain, Germany, The Netherlands, and Italy) were included in the study. Five single-nucleotide polymorphisms (SNPs) of CD40 (rs1883832, rs4810485, rs1535045) and CD40LG (rs3092952, rs3092920) were genotyped by using a predesigned TaqMan allele-discrimination assay technology. Meta-analysis was assessed to determine whether an association exists between the genetic variants and SSc or its main clinical subtypes.

resultsNo evidence of association between CD40 and CD40LG genes variants and susceptibility to SSc was observed. Similarly, no significant statistical differences were observed when SSc patients were stratified by the clinical subtypes, the serologic features, and pulmonary fibrosis.

conclusionsOur results do not suggest an important role of CD40 and CD40LG gene polymorphisms in the susceptibility to or clinical expression of SSc.

Indexed as

Polymorphism, Single NucleotideCD40 AntigensCD40 LigandGenetic Predisposition to DiseaseGenotypeHumansScleroderma, SystemicCD40 AntigensCD40 Ligand

Identifiers

PMID22731751
PMCPMC3446540
OpenAlexW2112943524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.